Shares issued under ESOP 2008 and MESOP 2018 plans following exercise of vested stock options, in compliance with SEBI disclosure norms
Denosumab biosimilars approved in Canada to expand access for osteoporosis and cancer-related bone conditions
Veteran pharma leader brings 33+ years of experience to drive operational excellence in formulation business
With a PhD in Biochemistry and an executive MBA, she brings nearly two decades of experience in the in vitro diagnostics (IVD) sector
Bulling brings extensive experience across the biopharma and CDMO landscape, with leadership roles spanning both drug substance and drug product operations
Move comes amid rising regulatory pressures
The study is being conducted through its Japan-based pharmaceutical arm, Asahi Kasei Therapeutics Corp
Policy symposium in Hyderabad focuses on life skills education and community?driven solutions
SBE303 targets Nectin-4, an adhesion protein overexpressed in multiple tumor types, including urothelial, lung, and breast cancers
The new facility is expected to significantly improve access to high-quality medical services for patients across Gujarat and neighbouring regions
Subscribe To Our Newsletter & Stay Updated
